SNM1B/Apollo in the DNA damage response and telomere maintenance

Maren Schmiester; Ilja Demuth

doi:10.18632/oncotarget.16864

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

SNM1B/Apollo in the DNA damage response and telomere maintenance

Maren Schmiester and Ilja Demuth _

PDF | HTML | How to cite

Oncotarget. 2017; 8:48398-48409. https://doi.org/10.18632/oncotarget.16864

Metrics: PDF 2593 views | HTML 4244 views | ?

Abstract

Maren Schmiester1,2 and Ilja Demuth1,2,3

1Lipid Clinic at the Interdisciplinary Metabolism Center, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany

2Institute of Medical and Human Genetics, Charité–Universitätsmedizin Berlin, 13353 Berlin, Germany

3Research Group on Geriatrics, Charité–Universitätsmedizin Berlin, 13347 Berlin, Germany

Correspondence to:

Ilja Demuth, email: [email protected]

Keywords: Apollo, hSNM1B, DCLRE1B, Fanconi anemia

Received: February 21, 2017 Accepted: March 27, 2017 Published: April 05, 2017

ABSTRACT

hSNM1B/Apollo is a member of the highly conserved β-CASP subgroup within the MBL superfamily of proteins. It interacts with several DNA repair proteins and functions within the Fanconi anemia pathway in response to DNA interstrand crosslinks. As a shelterin accessory protein, hSNM1B/Apollo is also vital for the generation and maintenance of telomeric overhangs. In this review, we will summarize studies on hSNM1B/Apollo's function, including its contribution to DNA damage signaling, replication fork maintenance, control of topological stress and telomere protection. Furthermore, we will highlight recent studies illustrating hSNM1B/Apollo’s putative role in human disease.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 16864

Publication Alerts

Post-Publication Promotion

Publication Discount

Reviews:

SNM1B/Apollo in the DNA damage response and telomere maintenance

Abstract